Researchers Examine Antidepressant Drugs to Treat Irrational Pain

by Shirley Johanna on March 18, 2015 at 12:27 PM
Researchers Examine Antidepressant Drugs to Treat Irrational Pain

Researchers at the University of Copenhagen investigate the effect of antidepressant drugs to treat pain 'catastrophizing' in patients those underwent surgery. Pain catastrophizing is an irrational thought process that leads a patient to believe that the pain is more than it actually is.

Antidepressant drugs might reduce pain catastrophizing, but according to a study published in the official medical journal of the American Society of Anesthesiologists, that may not be the case, at least for acute pain.


"Pain catastrophizing patients report more pain right after surgery, but whether or not targeted therapy can reduce pain among these patients had not been investigated," said Dr.Troels H. Lunn, MD, lead author, Department of Anaesthesiology and Intensive Care, University of Copenhagen, Denmark. "Our study was the first to investigate the effects of SSRIs (selective serotonin reuptake inhibitors, one class of antidepressants) on pain immediately after surgery."

Dr.Lunn and his colleagues studied 120 patients with pain catastrophizing disorder who were scheduled for total-knee replacement surgery. The patients were given either the escitalopram or a placebo daily from the day of surgery to the sixth day after surgery, in addition to a pain medication regime. Twenty-four hours after surgery, patients were asked to report their level of pain while walking. The researchers found that the antidepressant treatment did not reduce pain 24 hours after the procedure. They did, however, find that overall pain scores days two through six after surgery were reduced with the antidepressant treatment. According to Dr. Lunn, the findings suggest that initiating antidepressant treatment earlier may reduce pain immediately after surgery.

"This topic calls for future studies on the effect of this and other classes of antidepressants on postsurgical pain, and our study can serve as a basis for such research," said Dr. Lunn.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Drug News

Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
Anti-cancer Drug Navitoclax Help Treat Lower Back Pain
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Researchers Examine Antidepressant Drugs to Treat Irrational Pain Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests